At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 36 enrolled
Drug / intervention
Micafungin +1 moredrug
Likely dose
Micafungin 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacokinetic Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
University of Texas Southwestern Medical Center·interventional·Posted Mar 19, 2010·Updated Nov 27, 2020
In Brief
A Phase 4 clinical trial evaluating Micafungin for Obesity and 2 related conditions. Completed, enrolled 36 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the drug concentration of Micafungin amongst healthy volunteers having different weight groups.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Nutrition Disorders, Overweight
CountriesUnited States
CollaboratorsAstellas Pharma US, Inc.
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2009
First PostedMar 2010
Primary CompletionMay 2010
Study CompletionJun 2010
TodayJul 2026
First PostedMar 19, 2010
Enrollment StartNov 1, 2009
Primary CompletionMay 1, 2010
Study CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 16.3 years ago
Interventions
Micafungindrug
100 mg IV infusion over 1 hour
Micafungindrug
300 mg IV infusion over 1 hour